This meta‐analysis showed that the use of terlipressin with albumin in patients with liver cirrhosis and HRS is superior to placebo and albumin alone, regarding likelihood of HRS reversal, decrease in baseline serum Cr, with a trend toward less requirement of RRT at 30 days. The gene discussed is ALB; the disease is cirrhosis of liver.